surpass 2 tirzepatide In patients with type diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. ⁣, ⁣, Read the full SURPASS-CVOT Tirzepatide versus Semaglutide Once Weekly

Your clinician can help determine whether your spotting is a typical side effect of the medication or if further investigation is needed

Understanding how compounded medications workand when they may be consideredis important when exploring safe and responsible weight loss care

Customizable Treatment for Your Skins Needs One of the best things about IV Drip therapy is that it can be tailored to your specific needs

Jan 22, 2026 Something is wrong

Breast Cancer: A 3047% Risk Reduction Among the most clinically significant findings was a real-world cohort study presented at ASCO 2026, which reported that women with Type 2 diabetes or obesity using GLP-1 receptor agonists experienced a 30 to 47% reduction in breast cancer risk compared to non-users